ProfileGDS4718 / 204528_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 87% 85% 96% 83% 84% 97% 97% 88% 80% 87% 87% 91% 92% 97% 97% 91% 86% 95% 98% 97% 86% 88% 86% 84% 90% 97% 83% 97% 82% 98% 93% 98% 82% 80% 95% 97% 97% 90% 88% 97% 87% 95% 97% 98% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.7401187
GSM549102patient 115, normal, homogenized [OPG study]8.4084685
GSM549104patient 119, normal, homogenized [OPG study]10.530596
GSM549108patient 138, normal, homogenized [OPG study]8.1114983
GSM549119patient 077, normal, homogenized [OPG study]8.2451384
GSM549133patient 032, cancer, homogenized [OPG study]11.052197
GSM549139patient 042, cancer, homogenized [OPG study]10.907697
GSM549099patient 107, normal, homogenized [OPG study]8.7924588
GSM549109patient 139, normal, homogenized [OPG study]7.8331380
GSM549110patient 046, normal, homogenized [OPG study]8.7051487
GSM549114patient 063, normal, homogenized [OPG study]8.890587
GSM549122patient 082, normal, homogenized [OPG study]9.3524691
GSM549134patient 033, cancer, homogenized [OPG study]9.5025292
GSM549136patient 036, cancer, homogenized [OPG study]10.768397
GSM549140patient 044, cancer, homogenized [OPG study]10.894797
GSM549111patient 047, normal, homogenized [OPG study]9.4372291
GSM549113patient 057, normal, homogenized [OPG study]8.6992886
GSM549132patient 031, cancer, homogenized [OPG study]10.170495
GSM549137patient 038, cancer, homogenized [OPG study]11.206398
GSM549142patient 047, cancer, homogenized [OPG study]10.576597
GSM549100patient 110, normal, homogenized [OPG study]8.6192686
GSM549107patient 135, normal, homogenized [OPG study]8.9221188
GSM549115patient 068, normal, homogenized [OPG study]8.8437686
GSM549116patient 072, normal, homogenized [OPG study]8.4314784
GSM549120patient 078, normal, homogenized [OPG study]9.1369890
GSM549131patient 030, cancer, homogenized [OPG study]10.921497
GSM549118patient 074, normal, homogenized [OPG study]8.2586183
GSM549129patient 027, cancer, homogenized [OPG study]10.784297
GSM549123patient 088, normal, homogenized [OPG study]8.0355882
GSM549124patient 006, cancer, homogenized [OPG study]10.948698
GSM549126patient 015, cancer, homogenized [OPG study]9.735793
GSM549128patient 025, cancer, homogenized [OPG study]11.234598
GSM549103patient 117, normal, homogenized [OPG study]7.9546582
GSM549117patient 073, normal, homogenized [OPG study]7.8215380
GSM549138patient 041, cancer, homogenized [OPG study]10.116395
GSM549141patient 045, cancer, homogenized [OPG study]10.754897
GSM549130patient 028, cancer, homogenized [OPG study]10.552597
GSM549101patient 111, normal, homogenized [OPG study]9.0803990
GSM549105patient 128, normal, homogenized [OPG study]8.7700988
GSM549106patient 134, normal, homogenized [OPG study]11.041297
GSM549112patient 048, normal, homogenized [OPG study]8.7294787
GSM549125patient 011, cancer, homogenized [OPG study]10.049395
GSM549127patient 024, cancer, homogenized [OPG study]10.807897
GSM549135patient 035, cancer, homogenized [OPG study]11.236598